Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 99

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 99
---
25.2 million, inclusive of $0.2 million in excise tax, in common stock, representing 445,724 shares of our common stock at a weighted average cost per share of $56.09. At September 30, 2025, $328.4 million remained unused under the 2022 Authorization.

During the three and nine months ended September 30, 2024, we repurchased no common stock. 

Note 11: Restructuring and Other (Income) Charges, net

Detail on the restructuring charges and other (income) charges, net, is provided below.Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Restructuring charges$1.0 $2.0 $10.1 $3.4 Other (income) charges, net— 1.3 — 4.9 Total Restructuring and other (income) charges, net$1.0 $3.3 $10.1 $8.3 

21

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsSeptember 30, 2025(Unaudited)

Restructuring ChargesIn millionsSeverance and other employee-related costsOther charges (income) (1)Asset disposal chargesTotalPerformance Chemicals repositioning$— $0.7 $— $0.7 Other (2)0.1 0.2 — 0.3 Three Months Ended September 30, 2025$0.1 $0.9 $— $1.0 Performance Chemicals repositioning$1.3 $0.7 $— $2.0 Three Months Ended September 30, 2024$1.3 $0.7 $— $2.0 In millionsSeverance and other employee-related costsOther charges (income) (1)Asset disposal chargesTotalPerformance Chemicals repositioning$— $2.1 $— $2.1 Other (2)2.6 1.0 4.4 8.0 Nine Months Ended September 30, 2025$2.6 $3.1 $4.4 $10.1 Performance Chemicals repositioning$1.5 $1.9 $— $3